A Nobel Prize-Winning Drug Used 4 Billion Times in Humans — And the Media Called It “Horse Dewormer” to Protect a $100 Billion Revenue Stream

By Tony Huge, J.D. — Medical Lawyer | March 2026

The Most Successful Disinformation Campaign in Modern Medicine

In 2021, the American public witnessed something unprecedented: a coordinated media campaign to discredit one of the safest, most widely-used medications in human history. A drug that had been administered over 4 billion times to human beings. A drug that won the Nobel Prize in Physiology or Medicine in 2015. A drug on the WHO’s List of Essential Medicines — a designation reserved for the most important medications on the planet.

They called it “horse dewormer.”

Let me say that again so it registers: a Nobel Prize-winning medication, prescribed to humans for over 40 years, administered billions of times across the developing world, responsible for virtually eliminating river blindness and lymphatic filariasis — was deliberately rebranded as an animal medication by mainstream media outlets, social media platforms, and regulatory agencies.

Why? Because acknowledging ivermectin’s potential meant acknowledging that a $0.02-per-dose generic drug could compete with products generating over $100 billion in revenue. And under Emergency Use Authorization rules, existing treatments had to be deemed unavailable for new products to receive authorization.

This isn’t speculation. This is the regulatory framework as written. And the media campaign against ivermectin was the enforcement mechanism.

Who I Am and Why This Matters

My name is Tony Huge. I’m a medical lawyer with a J.D., and I’ve spent my career at the intersection of pharmaceutical regulation, medical freedom, and the truth that institutions try to suppress. I’ve been called the most censored person in health, wellness, and fitness — because I refuse to accept narratives designed to protect corporate profits at the expense of human health.

The ivermectin story isn’t about one drug. It’s about what happens when the pharmaceutical-regulatory-media complex decides that a cheap, safe, widely-available compound threatens their business model. It’s about the systematic suppression of scientific inquiry when that inquiry threatens revenue streams.

And it’s about your right to know the truth — a right that was deliberately violated on a global scale.

The Nobel Prize They Want You to Forget

In 2015, William C. Campbell and Satoshi Omura were awarded the Nobel Prize in Physiology or Medicine for their discovery of avermectin, from which ivermectin was derived. The Nobel Committee called it a drug that had “revolutionized therapy for patients suffering from devastating parasitic diseases.”

Ivermectin’s track record in humans:

• 4+ billion doses administered to humans worldwide since the 1980s
• WHO Essential Medicine — one of the most important medications in global health
• Virtually eliminated river blindness (onchocerciasis) in multiple African and Latin American countries
• Critical tool against lymphatic filariasis — a disease affecting 120 million people
• Safety profile established over 40+ years — one of the most well-characterized safety profiles of any drug in existence
• Side effects at therapeutic doses: Generally mild and transient — headache, dizziness, mild GI discomfort in a small percentage of patients

This is the drug they called “horse dewormer.” A medication with four decades of human safety data, billions of human doses, and a Nobel Prize.

The Research They Suppressed

What the media systematically refused to report was the growing body of research exploring ivermectin’s mechanisms beyond antiparasitic activity.

Published peer-reviewed research demonstrates that ivermectin has:

• Anti-inflammatory properties: Multiple studies have shown ivermectin modulates inflammatory pathways, including NF-kB and STAT3 signaling (Zaidi & Dehgani-Mobaraki, 2022)
• Antiviral mechanisms: In vitro studies have demonstrated activity against multiple RNA viruses through inhibition of importin alpha/beta nuclear transport (Caly et al., 2020, Antiviral Research)
• Anti-cancer research: Emerging research has explored ivermectin’s potential antiproliferative effects in multiple cancer cell lines, including breast, ovarian, and colon cancer models (Tang et al., 2021)
• Immunomodulatory effects: Research has shown ivermectin can modulate immune response through multiple mechanisms beyond its antiparasitic activity

Were all of these studies definitive? No. That’s how science works — evidence accumulates, hypotheses are tested, and conclusions emerge over time. But the response from the establishment wasn’t “let’s study this further.” It was “shut it down, censor anyone who discusses it, and call it horse paste.”

That’s not science. That’s suppression.

The EUA Problem: Why Ivermectin Had to Be Destroyed

Under FDA regulations, Emergency Use Authorization (EUA) can only be granted when “there is no adequate, approved, and available alternative to the product for diagnosing, preventing, or treating the disease or condition.”

Read that again carefully. If an existing, approved drug — like ivermectin — could be shown to have therapeutic benefit, the legal basis for EUA would be compromised. Not eliminated necessarily, but significantly complicated.

The financial stakes were astronomical:

• Products under EUA generated over $100 billion in revenue in 2021-2022
• Ivermectin costs approximately $0.02 per dose in generic form
• The generic was already manufactured globally and immediately available

The incentive to suppress ivermectin research wasn’t medical. It was financial. And the regulatory framework created the exact conditions under which that suppression became necessary for revenue protection.

This is regulatory capture in its most naked form: the rules themselves create incentives to suppress competing treatments, and the agencies charged with enforcing those rules are funded and influenced by the companies that benefit from suppression.

The Laws of Biochemistry Physics: Understanding What Was Suppressed

In my book Better Than Natural, I established the Tony Huge Laws of Biochemistry Physics — principles that explain how compounds interact with biological systems and why the establishment opposes certain interventions. Ivermectin is a textbook case.

Law 4: Every Biological Problem Has a Chemical Solution

Ivermectin is a multi-mechanism compound. Its biological activity extends far beyond parasite treatment because it interacts with multiple biological pathways — importin alpha/beta transport, inflammatory signaling cascades, and cellular proliferation mechanisms. The establishment wants you to believe that a drug can only do one thing. Biology says otherwise. Compounds interact with multiple receptor systems, multiple pathways, and multiple mechanisms. Ivermectin’s broad activity isn’t unusual — it’s expected for a molecule with its chemical properties.

The refusal to investigate these mechanisms isn’t scientific caution. It’s willful ignorance in service of profit.

Law 5: The Law of Utility vs. Toxicity

Ivermectin may have the most favorable utility-to-toxicity ratio of any drug in existence. Four billion doses. Forty-plus years. A side effect profile that most drug developers would consider miraculous. The minimum effective dose for antiparasitic activity is well-established, and the therapeutic window — the gap between effective dose and toxic dose — is enormous.

When media outlets showed images of horse-sized ivermectin paste tubes and implied that people were poisoning themselves, they were deliberately conflating veterinary dosing (designed for 1,200-pound animals) with human therapeutic dosing (designed for 150-pound humans). It was disinformation by conflation — taking a legitimate safety concern (don’t take veterinary formulations) and using it to discredit the entire compound.

Methodology 1: Knowledge is Freedom

The ivermectin story is the clearest modern example of epistemic oppression — the deliberate suppression of knowledge to maintain power. Doctors who prescribed ivermectin were threatened with license revocation. Pharmacists who filled prescriptions were pressured to refuse. Social media platforms censored any discussion of ivermectin research. Scientific journals faced pressure to retract or delay studies.

When the system controls what you’re allowed to know, they control what decisions you’re allowed to make. The suppression of ivermectin research wasn’t about protecting you from a dangerous drug. It was about protecting revenue from an informed public.

The Safety Record That Destroys the Narrative

Acetaminophen kills approximately 500 Americans annually and causes the majority of acute liver failure cases. NSAIDs kill approximately 17,000 Americans annually from GI bleeding and cardiovascular complications. These remain freely available, aggressively marketed, and never called “animal drugs” despite being used in veterinary medicine as well.

Ivermectin — with one of the safest profiles of any drug ever developed — was rebranded as animal medication. The selective application of the “danger” narrative tells you everything you need to know about who it serves.

Interesting Perspectives

The suppression of ivermectin research represents a pivotal case study in the politics of medicine. Beyond the immediate financial conflicts, this episode reveals deeper systemic biases. The dismissal of repurposed, multi-mechanism drugs in favor of novel, single-target agents reflects a pharmaceutical development model that prioritizes patentability over therapeutic utility. Ivermectin’s broad anti-inflammatory and immunomodulatory effects, which align with the principles of the Tony Huge Laws of Biochemistry Physics, challenge the simplistic “one drug, one target” dogma. This compound’s history forces a re-examination of what constitutes “evidence” in a crisis, highlighting how institutional gatekeeping can stall the investigation of promising, low-cost interventions in favor of more profitable pathways. The ongoing exploration of its potential in oncology and neurodegenerative diseases continues, often outside the mainstream funding channels, proving that scientific truth persists despite narrative suppression.

The System Is Built to Keep You Dependent

The ivermectin suppression story reveals the architecture of medical control:

Step 1: A cheap, safe, widely-available compound shows potential for a new application.

Step 2: That compound threatens the revenue of new, expensive, patented products.

Step 3: Regulatory agencies — funded by and revolving-door connected to pharmaceutical companies — suppress investigation of the cheap compound.

Step 4: Media outlets — dependent on pharmaceutical advertising revenue — amplify the suppression with coordinated messaging.

Step 5: Social media platforms — under pressure from regulators and advertisers — censor discussion of the cheap compound.

Step 6: The public is left with only one option: the expensive, patented product.

This isn’t a conspiracy theory. Every step is documented. Every financial incentive is transparent. Every institutional relationship is a matter of public record.

The system is built to keep you dependent on expensive solutions when cheap ones exist. It’s built to keep you ignorant of alternatives when alternatives threaten revenue. And it’s built to punish anyone who dares to tell you the truth.

I’ve been censored, deplatformed, and attacked for doing exactly that. And I’m not stopping.

The Post-Pandemic Reckoning

The truth has a way of emerging, even when suppressed. In the years since the “horse dewormer” campaign:

• Multiple countries that used ivermectin broadly have published their outcomes data
• Peer-reviewed research on ivermectin’s mechanisms has continued and expanded
• The scientific community has begun to reckon with the institutional failures of the suppression period
• Public trust in pharmaceutical companies and regulatory agencies has declined to historic lows
• Robert F. Kennedy Jr., now HHS Secretary, has been vocal about the need to re-examine drug repurposing and the conflicts of interest that drove suppression

The pendulum is swinging. But it’s swinging slowly, and the damage — to public trust, to scientific integrity, to individual patients who were denied access to a potential treatment — has already been done.

The Truth Is Non-Negotiable

Ivermectin is a Nobel Prize-winning medication with 40+ years of human safety data and 4+ billion human doses administered. Calling it “horse dewormer” was a deliberate act of disinformation designed to protect revenue, not patients.

The research into ivermectin’s broader mechanisms is legitimate, peer-reviewed, and ongoing. The suppression of that research was driven by financial conflicts of interest, not scientific evidence.

You had the right to know about this research. You had the right to discuss it with your doctor. You had the right to make an informed decision about your own health. Those rights were taken from you — not by science, but by a system that profits from your ignorance.

I don’t care how many times they censor me. The truth about ivermectin — and about every other compound the system suppresses to protect profits — will be told. Your health is not their commodity. Your decisions are not their property. Your freedom is not their permission to grant.

Citations & References

Related Reading

• Tony Huge Was Right About COVID: 6 Positions That Were Censored in 2020 and Vindicated by 2025
• The 5 Most Dangerous Biohacking Trends of 2023
• PEA (Palmitoylethanolamide): The Endocannabinoid Pain Killer
• Unlock Longevity with Low-Dose Rapamycin